| ²é¿´: 1086 | »Ø¸´: 1 | |||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßyangmeida½«ÔùËÍÄú 30 ¸ö½ð±Ò | |||
yangmeidaͳæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÎÄÏ× ÒÑÓÐ1È˲ÎÓë
|
||
| ÇóÎÄÏ×£¬¡°A survey of FDA Approved Monoclonal Antibodies and Fc-fusion Proteins for Manufacturing Changes and Comparability Assessment¡±£¬ PMID: 37910341 DOI: 10.1007/s11095-023-03627-5£¬ËÄÇÓÐ×ÊÔ´°ïæÏÂÔØÏÂÀ´£¬Ð»Ð»£¡ |
» ²ÂÄãϲ»¶
º£²ªÔ¸¨ÁÏÖúÁ¦ÒøÐ¼²¡Ò»ÏßÍâÓÃÖÆ¼Á¿ª·¢
ÒѾÓÐ0È˻ظ´
Çë½Ìִҵҩʦ±¨¿¼µÄһЩÎÊÌâ
ÒѾÓÐ4È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ216È˻ظ´
¶þÒÒÏ©»ùí¿µÄºÏ³É·¾¶
ÒѾÓÐ4È˻ظ´
ÇóÒ»Öê[b]ÇóýMTAP(human)µÄHCT-116(È˽᳦°©Ï¸°û)/b]ϸ°û
ÒѾÓÐ0È˻ظ´
Õâ¸ö×Ô·¢¼ÓÑõ·´Ó¦µÄ»úÀíÊÇʲô£¿
ÒѾÓÐ7È˻ظ´
ÇóÖú£¡ÇóÃÀ¹úʳƷ»¯Ñ§Ò©µäÄÚÈÝ£ºFCC13¡¾µÍ¾Û¹ûÌÇרÂÛ¡¿
ÒѾÓÐ0È˻ظ´
¡¾2027²©Ê¿ÉêÇë¡¿ÄÉÃ×Ò©ÎïµÝËÍ·½Ïò
ÒѾÓÐ5È˻ظ´
ÏûºÄ΢Á¿API£¬±ã¿ÉÔ¤²âÔçÆÚÑз¢½×¶ÎµÄHME¹¤ÒÕ¿ÉÐÐÐÔ
ÒѾÓÐ0È˻ظ´
·´Ó¦ÒºÖб½ôû³ýÈ¥
ÒѾÓÐ1È˻ظ´
lubenle
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 39247.7
- ºì»¨: 73
- Ìû×Ó: 4199
- ÔÚÏß: 658.9Сʱ
- ³æºÅ: 412363
- ×¢²á: 2007-06-25
- ÐÔ±ð: GG
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
| A survey of FDA Approved Monoclonal Antibodies and Fc-fusion Proteins for Manufacturing Changes and Comparability Assessment |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ASurveyofFDAApprovedMonoclonalAntibodiesandFcfusionProteinsforManufac.pdf
2026-01-21 13:54:39, 766.39 K

2Â¥2026-01-21 13:54:56









»Ø¸´´ËÂ¥
ͶƱ:
10